GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
၂,၄၇၄.၆၀ ₹
arrow_downward
-၀.၈၂%(-၂၀.၄၀) 1D
ဇူ ၂၄, GMT+၅:၃၀ ၁၂:၅၇:၂၃ · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
၂,၄၉၀.၂၀ ₹
High
၂,၅၀၄.၅၀ ₹
Low
၂,၄၅၅.၀၀ ₹
Mkt. cap
ဋေ ၄.၁၉ သ
Avg. vol.
၁.၁၆ သိန်း
Volume
၂.၃၁ သောင်း
Dividend
၂.၃၀%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၀.၄၇
52-wk high
၃,၂၂၀.၀၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၁.၁၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
Open
၂,၄၉၀.၂၀ ₹
High
၂,၅၀၄.၅၀ ₹
Low
၂,၄၅၅.၀၀ ₹
Mkt. cap
ဋေ ၄.၁၉ သ
Avg. vol.
၁.၁၆ သိန်း
Volume
၂.၃၁ သောင်း
Dividend
၂.၃၀%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၀.၄၇
52-wk high
၃,၂၂၀.၀၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၁.၁၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
News stories
From sources across the web
Simply Wall Street
·
ပြီးခဲ့သည့် ၅၇ မိနစ်
Shopify (NasdaqGS:SHOP) Launches Native DSCP Fulfillment Integration As Merchant Sales Hit Record
TradingView
·
ပြီးခဲ့သည့် ၄၆ မိနစ်
IXIC: Nasdaq Composite Falls 2.1% as AI Trade Unwinds, Mag 7 Sheds $800 Billion
MarketBeat
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
G-III Apparel Group (NASDAQ:GIII) Stock Crosses Above Two Hundred Day Moving Average - Time to Sell?
Bloomberg.com
·
ပြီးခဲ့သည့် ၁ နာရီ
Asian Stocks Set to Fall as Oil Surges Past $100: Markets Wrap
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
AI content may include mistakes. Learn more